Market Closed -
Japan Exchange
02:00:00 2024-05-31 am EDT
|
5-day change
|
1st Jan Change
|
155
JPY
|
+1.31%
|
|
-1.27%
|
+14.81%
|
Fiscal Period: December |
2022
|
2023
|
---|
Capitalization
1 |
3,296
|
3,272
|
Enterprise Value (EV)
1 |
1,051
|
1,479
|
P/E ratio
|
-2.52
x
|
-3.41
x
|
Yield
|
-
|
-
|
Capitalization / Revenue
|
3,296
x
|
-
|
EV / Revenue
|
1,051
x
|
-
|
EV / EBITDA
|
-0.91
x
|
-1.55
x
|
EV / FCF
|
-
|
-2,209,828
x
|
FCF Yield
|
-
|
-0%
|
Price to Book
|
1.22
x
|
1.42
x
|
Nbr of stocks (in thousands)
|
21,400
|
24,236
|
Reference price
2 |
154.0
|
135.0
|
Announcement Date
|
3/30/23
|
3/28/24
|
Fiscal Period: December |
2022
|
2023
|
---|
Net sales
1 |
1
|
-
|
EBITDA
1 |
-1,156
|
-952
|
EBIT
1 |
-1,169
|
-994
|
Operating Margin
|
-116,900%
|
-
|
Earnings before Tax (EBT)
1 |
-1,174
|
-940
|
Net income
1 |
-1,172
|
-933
|
Net margin
|
-117,200%
|
-
|
EPS
2 |
-61.01
|
-39.61
|
Free Cash Flow
|
-
|
-669.2
|
FCF margin
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
Dividend per Share
|
-
|
-
|
Announcement Date
|
3/30/23
|
3/28/24
|
Fiscal Period: December |
2022 S1
|
2023 Q1
|
2023 S1
|
2023 Q3
|
2024 Q1
|
---|
Net sales
|
-
|
-
|
-
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-
|
-378
|
-622
|
-183
|
-183
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-
|
-343
|
-589
|
-163
|
-170
|
Net income
1 |
-
|
-341
|
-585
|
-161
|
-168
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
-
|
-15.47
|
-25.49
|
-6.480
|
-6.880
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
8/12/22
|
5/15/23
|
8/14/23
|
11/14/23
|
5/13/24
|
Fiscal Period: December |
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
Net Cash position
1 |
2,245
|
1,793
|
Leverage (Debt/EBITDA)
|
-
|
-
|
Free Cash Flow
|
-
|
-669
|
ROE (net income / shareholders' equity)
|
-
|
-37.4%
|
ROA (Net income/ Total Assets)
|
-
|
-22.7%
|
Assets
1 |
-
|
4,117
|
Book Value Per Share
2 |
126.0
|
94.90
|
Cash Flow per Share
2 |
105.0
|
74.00
|
Capex
1 |
13
|
1
|
Capex / Sales
|
1,300%
|
-
|
Announcement Date
|
3/30/23
|
3/28/24
|
|
1st Jan change
|
Capi.
|
---|
| +14.81% | 25.64M | | +43.36% | 54.64B | | -5.31% | 39.92B | | +37.52% | 38.82B | | +14.75% | 26.86B | | -12.56% | 26.22B | | -22.45% | 18.78B | | +25.12% | 12.21B | | +0.04% | 12.16B | | +26.04% | 11.94B |
Other Biotechnology & Medical Research
|